Treatment of Upper-Extremity Deep Vein Thrombosis When No Risk Factor or Venous Thoracic Outlet Syndrome Is Identified
This protocol addresses idiopathic upper-extremity deep vein thrombosis (UEDVT): presentations in which no obvious precipitating risk factor and no underlying venous thoracic outlet syndrome (VTOS) can be identified. The absence of a clear cause directly informs both treatment selection and duration of therapy.
Approach overview
Management centres on anticoagulation therapy, with cancer screening incorporated into the initial evaluation. The complete structured regimen — including sequencing and duration considerations specific to idiopathic proximal UEDVT, which differ from those for lower-extremity idiopathic thrombosis — is available via the full protocol below.
References
DOI: 10.1161/circulationaha.111.051276
- In patients with idiopathic UEDVT, no obvious risk factor or underlying VTOS can be identified.
- For idiopathic UEDVT: perform cancer screening.
- Anticoagulation therapy should be undertaken with a once-daily regimen of LMWH or fondaparinux for at least 5 days, followed by vitamin K antagonists for at least 3 months.
- In contrast to idiopathic lower-extremity thrombosis, extended anticoagulation therapy beyond 3 months is generally not recommended after a first episode of idiopathic proximal UEDVT.